To access this element change to forms mode OFF
Grant Award View - GA32401
Analysing the immune response and optimising the effectiveness of...
GA ID:
GA32401
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
17-Jan-2019
Category:
Medical Research
Grant Term:
1-Jan-2019 to 28-Feb-2021
Value (AUD):
$94,405.89
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Analysing the immune response and optimising the effectiveness of Mesothelin CAR T-cell therapy in cancer.
Purpose:
Chimeric Antigen Receptor (CAR) T-cells have engineered receptors attached to patient immune cells. They target cancer with less risk of damage to healthy cells. Our laboratory manufactures CAR T-cells targeting a tumour marker- mesothelin, found on pancreatic and other cancers. I plan to test these CAR T-cells in vitro and in mice followed by enrolling cancer patients in a clinical trial of CAR T-cells. My aim is to monitor safety, efficacy and help improve patient survival and quality of life.
GO ID:
GO Title:
NHMRC Postgraduate Scholarships for funding commencing in 2019
Internal Reference ID:
GNT1169460
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Centenary Institute of Cancer Medicine and Cell Biology
Recipient ABN:
22 654 201 090
Grant Recipient Location
Suburb:
Camperdown
Town/City:
Camperdown
Postcode:
2050
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA